Get all your news in one place.
100's of premium titles.
One app.
Start reading
LiveScience
LiveScience
Nicoletta Lanese

FDA approves 1st RSV vaccine for use in pregnancy to stop infection in newborns

a pregnant woman wearing a pink shirt and blue surgical mask sits as a standing medical provider prepares to give her a vaccine in her right arm

A respiratory syncytial virus (RSV) vaccine has just been approved for use in pregnant people that protects against dangerous infection in newborns. 

On Monday (Aug. 21), the Food and Drug Administration (FDA) announced the approval of Abrysvo, a vaccine made by Pfizer, for use in pregnant individuals. The shot had already been cleared for use in people ages 60 and up, but now, it can also be given in the third trimester of pregnancy, specifically between weeks 32 and 36 of gestation. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.